Print Page     Close Window     

SEC Filings

10-K
SERES THERAPEUTICS, INC. filed this Form 10-K on 03/06/2019
Entire Document
 

 

 

 

 

Incorporated by Reference

 

Filed/

Exhibit

Number

 

Exhibit Description

 

Form

 

File No.

 

Exhibit

 

Filing

Date

 

Furnished

Herewith

 

 

 

 

 

 

 

 

 

 

 

 

 

10.15#

 

Amendment to Employment Agreement, dated August 7, 2015 by and between the Registrant and Michele

Trucksis

 

10-Q

 

001-37465

 

10.12

 

8/10/15

 

 

10.16#

 

Amendment to Employment Agreement, dated March 7, 2018 by and between the Registrant and Michele Trucksis

 

10-K

 

001-37465

 

10.19

 

3/8/18

 

 

10.17#

 

Separation Agreement and Release, dated November 16, 2018, by and between the Registrant and Michele Trucksis

 

8-K

 

001-37465

 

10.1

 

11/21/18

 

 

10.18#

 

Consulting Agreement, dated November 16, 2018, by and between the Registrant and Michele Trucksis

 

8-K

 

001-37465

 

10.2

 

11/21/18

 

 

10.19#

 

Employment Agreement, dated April 26, 2016 by and between the Registrant and Thomas J. DesRosier

 

10-Q

 

001-37465

 

10.1

 

8/11/16

 

 

10.20#

 

Employment Agreement, dated October 5, 2018, by and between the Registrant and Kevin Horgan

 

10-Q

 

001-37465

 

10.1

 

11/08/18

 

 

10.21^

 

Collaboration and License Agreement, dated January 9, 2016, by and between the Registrant and Nestec Ltd.

 

10-Q

 

001-37465

 

10.1

 

5/16/16

 

 

10.22

 

Amendment No 1 to the Collaboration and License Agreement, dated August 10, 2016, by and between the Registrant and Nestec Ltd.

 

 

 

 

 

 

 

 

 

*

10.23^^

 

Letter Agreement dated October 30, 2018, by and between the Registrant and Nestec Ltd.

 

 

 

 

 

 

 

 

 

*

21.1

 

Subsidiaries of Seres Therapeutics, Inc.

 

 

 

 

 

 

 

 

 

*

23.1

 

Consent of PricewaterhouseCoopers LLP, Independent Registered Public Accounting Firm

 

 

 

 

 

 

 

 

 

*

31.1

 

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer

 

 

 

 

 

 

 

 

 

*

32.1

 

Section 1350 Certification of Chief Executive Officer

 

 

 

 

 

 

 

 

 

**

101.INS

 

XBRL Instance Document

 

 

 

 

 

 

 

 

 

*

101.SCH

 

XBRL Taxonomy Extension Schema Document

 

 

 

 

 

 

 

 

 

*

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase Document

 

 

 

 

 

 

 

 

 

*

101.LAB

 

XBRL Taxonomy Extension Label Linkbase Document

 

 

 

 

 

 

 

 

 

*

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

 

 

 

 

 

 

 

*

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase Document

 

 

 

 

 

 

 

 

 

*

 

*

Filed herewith.

**

Furnished herewith.

#

Indicates management contract or compensatory plan.

^

Confidential treatment has been granted with respect to redacted portions of this exhibit. Redacted portions of this exhibit have been filed separately with the SEC.

^^

Confidential treatment has been requested with respect to redacted portions of this exhibit. Redacted portions of this exhibit have been filed separately with the SEC.

 

Item 16. Form 10-K Summary

 

None.

 

 

92



© Seres Therapeutics. All Rights Reserved.